472 related articles for article (PubMed ID: 25583483)
1. STEP61 is a substrate of the E3 ligase parkin and is upregulated in Parkinson's disease.
Kurup PK; Xu J; Videira RA; Ononenyi C; Baltazar G; Lombroso PJ; Nairn AC
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1202-7. PubMed ID: 25583483
[TBL] [Abstract][Full Text] [Related]
2. Alterations in STriatal-Enriched protein tyrosine Phosphatase expression, activation, and downstream signaling in early and late stages of the YAC128 Huntington's disease mouse model.
Gladding CM; Fan J; Zhang LY; Wang L; Xu J; Li EH; Lombroso PJ; Raymond LA
J Neurochem; 2014 Jul; 130(1):145-59. PubMed ID: 24588402
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of the parkin substrate, FAF1, plays a key role in the dopaminergic neurodegeneration.
Sul JW; Park MY; Shin J; Kim YR; Yoo SE; Kong YY; Kwon KS; Lee YH; Kim E
Hum Mol Genet; 2013 Apr; 22(8):1558-73. PubMed ID: 23307929
[TBL] [Abstract][Full Text] [Related]
4. Striatal-enriched protein tyrosine phosphatase regulates the PTPα/Fyn signaling pathway.
Xu J; Kurup P; Foscue E; Lombroso PJ
J Neurochem; 2015 Aug; 134(4):629-41. PubMed ID: 25951993
[TBL] [Abstract][Full Text] [Related]
5. Parkin promotes proteasomal degradation of synaptotagmin IV by accelerating polyubiquitination.
Kabayama H; Tokushige N; Takeuchi M; Kabayama M; Fukuda M; Mikoshiba K
Mol Cell Neurosci; 2017 Apr; 80():89-99. PubMed ID: 28254618
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of BDNF in cell and animal models increases striatal-enriched protein tyrosine phosphatase 61 (STEP61 ) levels.
Xu J; Kurup P; Azkona G; Baguley TD; Saavedra A; Nairn AC; Ellman JA; Pérez-Navarro E; Lombroso PJ
J Neurochem; 2016 Jan; 136(2):285-94. PubMed ID: 26316048
[TBL] [Abstract][Full Text] [Related]
7. Parkin-mediated protection of dopaminergic neurons in a chronic MPTP-minipump mouse model of Parkinson disease.
Yasuda T; Hayakawa H; Nihira T; Ren YR; Nakata Y; Nagai M; Hattori N; Miyake K; Takada M; Shimada T; Mizuno Y; Mochizuki H
J Neuropathol Exp Neurol; 2011 Aug; 70(8):686-97. PubMed ID: 21760537
[TBL] [Abstract][Full Text] [Related]
8. Dyrk1A phosphorylates parkin at Ser-131 and negatively regulates its ubiquitin E3 ligase activity.
Im E; Chung KC
J Neurochem; 2015 Aug; 134(4):756-68. PubMed ID: 25963095
[TBL] [Abstract][Full Text] [Related]
9. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphatase STEP61 negatively regulates amyloid β-mediated ERK/CREB signaling pathways via α7 nicotinic acetylcholine receptors.
Zhang L; Xie JW; Yang J; Cao YP
J Neurosci Res; 2013 Dec; 91(12):1581-90. PubMed ID: 24123152
[TBL] [Abstract][Full Text] [Related]
11. Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson's disease.
Imam SZ; Zhou Q; Yamamoto A; Valente AJ; Ali SF; Bains M; Roberts JL; Kahle PJ; Clark RA; Li S
J Neurosci; 2011 Jan; 31(1):157-63. PubMed ID: 21209200
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function.
Ko HS; Lee Y; Shin JH; Karuppagounder SS; Gadad BS; Koleske AJ; Pletnikova O; Troncoso JC; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 2010 Sep; 107(38):16691-6. PubMed ID: 20823226
[TBL] [Abstract][Full Text] [Related]
13. Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity.
Yao D; Gu Z; Nakamura T; Shi ZQ; Ma Y; Gaston B; Palmer LA; Rockenstein EM; Zhang Z; Masliah E; Uehara T; Lipton SA
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10810-4. PubMed ID: 15252205
[TBL] [Abstract][Full Text] [Related]
14. Covalent ISG15 conjugation positively regulates the ubiquitin E3 ligase activity of parkin.
Im E; Yoo L; Hyun M; Shin WH; Chung KC
Open Biol; 2016 Aug; 6(8):. PubMed ID: 27534820
[TBL] [Abstract][Full Text] [Related]
15. PICK1 inhibits the E3 ubiquitin ligase activity of Parkin and reduces its neuronal protective effect.
He J; Xia M; Yeung PKK; Li J; Li Z; Chung KK; Chung SK; Xia J
Proc Natl Acad Sci U S A; 2018 Jul; 115(30):E7193-E7201. PubMed ID: 29987020
[TBL] [Abstract][Full Text] [Related]
16. The role of parkin in the differential susceptibility of tuberoinfundibular and nigrostriatal dopamine neurons to acute toxicant exposure.
Benskey MJ; Manfredsson FP; Lookingland KJ; Goudreau JL
Neurotoxicology; 2015 Jan; 46():1-11. PubMed ID: 25447324
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38/JTV-1, leads to catecholaminergic cell death.
Ko HS; von Coelln R; Sriram SR; Kim SW; Chung KK; Pletnikova O; Troncoso J; Johnson B; Saffary R; Goh EL; Song H; Park BJ; Kim MJ; Kim S; Dawson VL; Dawson TM
J Neurosci; 2005 Aug; 25(35):7968-78. PubMed ID: 16135753
[TBL] [Abstract][Full Text] [Related]
18. Parkin-associated Parkinson's disease.
von Coelln R; Dawson VL; Dawson TM
Cell Tissue Res; 2004 Oct; 318(1):175-84. PubMed ID: 15503153
[TBL] [Abstract][Full Text] [Related]
19. Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson's disease.
Romaní-Aumedes J; Canal M; Martín-Flores N; Sun X; Pérez-Fernández V; Wewering S; Fernández-Santiago R; Ezquerra M; Pont-Sunyer C; Lafuente A; Alberch J; Luebbert H; Tolosa E; Levy OA; Greene LA; Malagelada C
Cell Death Dis; 2014 Aug; 5(8):e1364. PubMed ID: 25101677
[TBL] [Abstract][Full Text] [Related]
20. Parkin-knockout mice did not display increased vulnerability to intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Aguiar AS; Tristão FS; Amar M; Chevarin C; Lanfumey L; Mongeau R; Corti O; Prediger RD; Raisman-Vozari R
Neurotox Res; 2013 Aug; 24(2):280-7. PubMed ID: 23588969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
